OTCMKTS:BAYRY - Bayer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$31.5250 -0.15 (-0.47 %)
(As of 06/17/2018 04:00 PM ET)
Previous Close$31.5250
Today's Range$30.74 - $31.90
52-Week Range$27.60 - $35.41
Volume386,341 shs
Average Volume489,027 shs
Market Capitalization$104.28 billion
P/E Ratio16.59
Dividend Yield1.80%
Beta1.18

About Bayer (OTCMKTS:BAYRY)

Bayer logoBayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BAYRY
CUSIPN/A
Phone49-21-4-30-1

Debt

Debt-to-Equity Ratio0.32
Current Ratio2.53
Quick Ratio2.04

Price-To-Earnings

Trailing P/E Ratio16.59
Forward P/E Ratio15.68
P/E Growth2.41

Sales & Book Value

Annual Sales$39.55 billion
Price / Sales2.64
Cash Flow$2.6581 per share
Price / Cash11.86
Book Value$12.60 per share
Price / Book2.50

Profitability

EPS (Most Recent Fiscal Year)$1.90
Net Income$8.29 billion
Net Margins11.96%
Return on Equity17.97%
Return on Assets7.87%

Miscellaneous

Employees115,200
Outstanding Shares3,307,800,000

Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How often does Bayer pay dividends? What is the dividend yield for Bayer?

Bayer declared an annual dividend on Monday, March 19th. Shareholders of record on Tuesday, May 29th will be given a dividend of $0.614 per share on Monday, June 11th. The ex-dividend date of this dividend is Friday, May 25th. View Bayer's Dividend History.

How were Bayer's earnings last quarter?

Bayer AG (OTCMKTS:BAYRY) issued its earnings results on Thursday, October, 29th. The company reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.65 by $0.23. The company had revenue of $12.28 billion for the quarter, compared to analyst estimates of $12.79 billion. Bayer had a return on equity of 17.97% and a net margin of 11.96%. View Bayer's Earnings History.

When is Bayer's next earnings date?

Bayer is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Bayer.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Johannes M. Dietsch, Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board (Age 56)
  • Mr. Liam Condon, CEO & Pres of Bayer Cropscience and Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)

Has Bayer been receiving favorable news coverage?

News articles about BAYRY stock have trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Bayer earned a coverage optimism score of 0.13 on Accern's scale. They also assigned news coverage about the company an impact score of 45.80 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Bayer?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer's stock price today?

One share of BAYRY stock can currently be purchased for approximately $31.5250.

How big of a company is Bayer?

Bayer has a market capitalization of $104.28 billion and generates $39.55 billion in revenue each year. The company earns $8.29 billion in net income (profit) each year or $1.90 on an earnings per share basis. Bayer employs 115,200 workers across the globe.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]


MarketBeat Community Rating for Bayer (BAYRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  207 (Vote Outperform)
Underperform Votes:  260 (Vote Underperform)
Total Votes:  467
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer (OTCMKTS:BAYRY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Bayer in the last 12 months. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.502.80
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Bayer (OTCMKTS:BAYRY) Consensus Price Target History

Price Target History for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/17/2018DZ BankReiterated RatingBuyView Rating Details
9/25/2017BNP ParibasUpgradeNeutral ➝ OutperformView Rating Details
7/3/2017Berenberg BankDowngradeBuy ➝ HoldView Rating Details
2/24/2017Sanford C. BernsteinReiterated RatingOutperformView Rating Details
1/4/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightView Rating Details
12/19/2016Jefferies Financial GroupUpgradeHold ➝ BuyView Rating Details
12/7/2016UBS GroupUpgradeNeutral ➝ BuyView Rating Details
9/14/2016Goldman Sachs GroupReiterated RatingBuyView Rating Details
8/25/2016CitigroupUpgradeNeutral ➝ BuyView Rating Details
(Data available from 6/17/2016 forward)

Earnings

Bayer (OTCMKTS:BAYRY) Earnings History and Estimates Chart

Earnings by Quarter for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.65$0.65$0.65

Bayer (OTCMKTS BAYRY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2018        
2/28/2018Q4 2017$0.31$0.42$10.1235 billionViewN/AView Earnings Details
10/26/2017Q3 2017$0.29$0.43$9.7001 billionViewN/AView Earnings Details
7/27/20176/30/2017$1.87$1.99$14.4512 billion$13.4097 billionViewN/AView Earnings Details
4/27/20173/31/2017$2.40$2.80$13.6505 billion$14.1120 billionViewN/AView Earnings Details
10/26/2016Q3$1.80$1.93$12.3939 billion$12.5666 billionViewListenView Earnings Details
7/27/2016Q2 2016$0.55$0.59$13.4544 billion$13.3641 billionViewN/AView Earnings Details
4/26/2016Q1 2016$0.62$0.65$13.5773 billion$13.1716 billionViewN/AView Earnings Details
2/25/2016Q4 2015$0.33$0.29$12.2810 billion$12.3988 billionViewN/AView Earnings Details
10/29/2015Q3$1.65$1.88$12.7909 billion$12.2765 billionViewListenView Earnings Details
7/29/2015Q2 2015$0.51$0.55$13.5767 billion$13.3752 billionViewN/AView Earnings Details
4/30/2015Q1 2015$2.35$2.33$12.8097 billion$13.4515 billionViewN/AView Earnings Details
2/26/2015Q4 2014$1.35$12.5311 billionViewN/AView Earnings Details
10/30/2014Q3 2014$0.43$12.9651 billionViewN/AView Earnings Details
7/30/2014Q2 2014$2.05$14.0189 billionViewN/AView Earnings Details
4/24/2014Q1 2014$2.47$2.35$14.6653 billion$14.5944 billionViewN/AView Earnings Details
2/28/2014Q4 2013$0.38$13.5471 billionViewN/AView Earnings Details
10/31/2013Q3 2013$0.42$12.7741 billionViewN/AView Earnings Details
7/31/2013Q2 2013$0.51$13.7399 billionViewN/AView Earnings Details
4/25/2013Q1 2013$0.55$13.3473 billionViewN/AView Earnings Details
2/28/2013Q4 2012$0.37$0.32ViewN/AView Earnings Details
10/30/2012Q3 2012$0.38ViewN/AView Earnings Details
7/31/2012Q2 2012$0.47ViewN/AView Earnings Details
4/26/2012Q1 2012$0.56ViewN/AView Earnings Details
2/28/2012Q4 2011$0.32$0.33ViewN/AView Earnings Details
10/26/2011Q3 2011$0.34$0.39ViewN/AView Earnings Details
7/28/2011Q2 2011$0.38$0.47ViewN/AView Earnings Details
4/27/2011Q1 2011$0.32$0.28ViewN/AView Earnings Details
2/28/2011Q4 2010$0.33ViewN/AView Earnings Details
11/1/2010Q3 2010$0.11ViewN/AView Earnings Details
7/30/2010Q2 2010$0.33$0.20ViewN/AView Earnings Details
4/29/2010Q1 2010$0.40ViewN/AView Earnings Details
11/23/2009Q3 2009$0.21$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Bayer (OTCMKTS:BAYRY) Dividend Information

Bayer pays an annual dividend of $0.57 per share, with a dividend yield of 1.81%. BAYRY's most recent annual dividend payment was Monday, June 11. Bayer pays out 30.00% of its earnings out as a dividend.
Most Recent Dividend:6/11/2018
Annual Dividend:$0.57
Dividend Yield:1.81%
Payout Ratio(s):30.00% (Trailing 12 Months of Earnings)
28.36% (Based on This Year's Estimates)
25.56% (Based on Next Year's Estimates)
21.44% (Based on Cash Flow)
Dividend Payments by Quarter for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/19/2018Annual$0.61405/25/20185/29/20186/11/2018
6/29/2017Annual$2.15705/1/20175/3/20175/15/2017
(Data available from 1/1/2013 forward)

Insider Trades

Bayer (OTCMKTS BAYRY) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.82%
Insider Trading History for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS BAYRY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Bayer (OTCMKTS BAYRY) News Headlines

Source:
DateHeadline
Biotech Firms Run Away After Industry Party With Topless DancersBiotech Firms Run Away After Industry Party With Topless Dancers
www.bloomberg.com - June 14 at 9:04 AM
Should Bayer Aktiengesellschaft’s (FRA:BAYN) Recent Earnings Decline Worry You?Should Bayer Aktiengesellschaft’s (FRA:BAYN) Recent Earnings Decline Worry You?
finance.yahoo.com - June 12 at 8:58 AM
Warren Buffetts Cash "Problem" Just Got $2.4 Billion WorseWarren Buffett's Cash "Problem" Just Got $2.4 Billion Worse
www.fool.com - June 8 at 4:45 PM
Bayer To Complete Monsanto Acquisition - Quick FactsBayer To Complete Monsanto Acquisition - Quick Facts
www.rttnews.com - June 4 at 9:02 AM
Bayer cash call for Monsanto dealBayer cash call for Monsanto deal
seekingalpha.com - June 4 at 9:02 AM
Bayer Announces EUR 6 Bln Cash Call To Finance Monsanto DealBayer Announces EUR 6 Bln Cash Call To Finance Monsanto Deal
www.rttnews.com - June 3 at 6:24 PM
Bayer set to close Monsanto takeover on Thursday: reportBayer set to close Monsanto takeover on Thursday: report
finance.yahoo.com - June 3 at 8:58 AM
Bayer to sell $9 billion in assets ahead of Monsanto tie-up — largest divestiture ever for a U.S. dealBayer to sell $9 billion in assets ahead of Monsanto tie-up — largest divestiture ever for a U.S. deal
www.marketwatch.com - June 1 at 9:17 AM
Bayer teams up with U.S. DOE for radioisotope in XofigoBayer teams up with U.S. DOE for radioisotope in Xofigo
seekingalpha.com - June 1 at 9:17 AM
Bayer wins US nod for Monsanto deal to create agriculture giantBayer wins US nod for Monsanto deal to create agriculture giant
www.reuters.com - May 31 at 9:26 AM
Bayer AG (ADR) (OTCMKTS:BAYRY) To Divest Assets Worth $9 Billion As A Result Of Antitrust Issues In The USBayer AG (ADR) (OTCMKTS:BAYRY) To Divest Assets Worth $9 Billion As A Result Of Antitrust Issues In The US
finance.yahoo.com - May 31 at 9:26 AM
Germanys Bayer reviewing R&D locations at pharma businessGermany's Bayer reviewing R&D locations at pharma business
finance.yahoo.com - May 31 at 9:26 AM
KWS bows out of bid to buy Bayers vegetable businessKWS bows out of bid to buy Bayer's vegetable business
www.reuters.com - May 30 at 4:42 PM
Bayer Supports United Fresh Start Foundation with $40000 to Increase Childrens Access to Fresh Fruits and VegetablesBayer Supports United Fresh Start Foundation with $40000 to Increase Children's Access to Fresh Fruits and Vegetables
www.prnewswire.com - May 30 at 4:42 PM
Bayers Generic Competition, Pipeline Setback Issues RemainBayer's Generic Competition, Pipeline Setback Issues Remain
www.nasdaq.com - May 30 at 9:13 AM
Bayer could get US approval for Monsanto deal on Tuesday: sourceBayer could get US approval for Monsanto deal on Tuesday: source
finance.yahoo.com - May 29 at 4:43 PM
US forces Germanys Bayer to shed $9 billion in ag business in biggest ever antitrust sell-offUS forces Germany's Bayer to shed $9 billion in ag business in biggest ever antitrust sell-off
www.cnbc.com - May 29 at 12:53 PM
KWS makes rival bid for Bayers vegetable seed businessKWS makes rival bid for Bayer's vegetable seed business
www.bizjournals.com - May 29 at 9:01 AM
Journal Profile: Owner of Milk + Honey spas ready to grow nationwideJournal Profile: Owner of Milk + Honey spas ready to grow nationwide
www.bizjournals.com - May 25 at 9:03 AM
Bayer cuts Monsanto earnings synergies outlook by $300MBayer cuts Monsanto earnings synergies outlook by $300M
seekingalpha.com - May 25 at 9:03 AM
Market Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing RobotsMarket Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing Robots
finance.yahoo.com - May 23 at 4:52 PM
Bayer Presents Preliminary Insights from Global Patient Survey at World Federation of Hemophilia 2018 World CongressBayer Presents Preliminary Insights from Global Patient Survey at World Federation of Hemophilia 2018 World Congress
www.prnewswire.com - May 23 at 8:56 AM
Covestro to Cut Its Teeth on Small M&A Before Unlocking BillionsCovestro to Cut Its Teeth on Small M&A Before Unlocking Billions
finance.yahoo.com - May 23 at 8:56 AM
Comparing Bayer (BAYRY) & Its PeersComparing Bayer (BAYRY) & Its Peers
www.americanbankingnews.com - May 22 at 7:24 PM
Vanessa Bayer Feared Doing The Porn Stars Skit With Donald Trump On SNLVanessa Bayer Feared Doing The 'Porn Stars' Skit With Donald Trump On 'SNL'
www.huffingtonpost.com - May 22 at 9:01 AM
CCI clears Bayers deal for MonsantoCCI clears Bayer's deal for Monsanto
finance.yahoo.com - May 22 at 9:01 AM
Indian regulator clears Bayers deal for MonsantoIndian regulator clears Bayer's deal for Monsanto
finance.yahoo.com - May 22 at 9:01 AM
Bayer Declares Annual Dividend of $0.61 (BAYRY)Bayer Declares Annual Dividend of $0.61 (BAYRY)
www.americanbankingnews.com - May 20 at 8:00 AM
El futbolista Jérôme Boateng prepara una colección de diseño con /NydenEl futbolista Jérôme Boateng prepara una colección de diseño con /Nyden
www.prnewswire.com - May 17 at 10:30 PM
Le footballeur Jérôme Boateng va dessiner une collection avec /NydenLe footballeur Jérôme Boateng va dessiner une collection avec /Nyden
www.prnewswire.com - May 17 at 8:15 PM
Piłkarz Jérôme Boateng zaprojektuje kolekcję z /NydenPiłkarz Jérôme Boateng zaprojektuje kolekcję z /Nyden
www.prnewswire.com - May 17 at 6:27 PM
Bayer (BAYRY) Rating Reiterated by DZ BankBayer (BAYRY) Rating Reiterated by DZ Bank
www.americanbankingnews.com - May 17 at 4:52 PM
BRIEF-Bayer Cropscience Agreed To Settle A Lawsuit Brought By Calyxt In Delaware Chancery CourtBRIEF-Bayer Cropscience Agreed To Settle A Lawsuit Brought By Calyxt In Delaware Chancery Court
www.reuters.com - May 16 at 9:22 AM
Bayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2018 International ConferenceBayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2018 International Conference
www.prnewswire.com - May 15 at 9:37 AM
Why Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings SeasonWhy Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings Season
finance.yahoo.com - May 15 at 9:37 AM
Jan Price, National Director of Womens HealthCare and Neurology Medical Science Liaisons Teams at Bayer ...Jan Price, National Director of Women's HealthCare and Neurology Medical Science Liaisons Teams at Bayer ...
www.prnewswire.com - May 11 at 9:54 AM
BRIEF-Bayer Receives Approval For Eylea In ChinaBRIEF-Bayer Receives Approval For Eylea In China
www.reuters.com - May 11 at 9:54 AM
Roches doublet therapy fails to beat Bayers Stivarga in late-stage CRC studyRoche's doublet therapy fails to beat Bayer's Stivarga in late-stage CRC study
seekingalpha.com - May 10 at 7:31 AM
Monsanto CEO to Leave After Sale to BayerMonsanto CEO to Leave After Sale to Bayer
www.wsj.com - May 9 at 9:13 AM
Face of GMOs at Monsanto to Step Down as Bayer Takeover ClosesFace of GMOs at Monsanto to Step Down as Bayer Takeover Closes
www.bloomberg.com - May 8 at 9:07 AM
BRIEF-Monsanto CEO Announces Intent To Leave Co Upon Closing Of Bayer AcquisitionBRIEF-Monsanto CEO Announces Intent To Leave Co Upon Closing Of Bayer Acquisition
www.reuters.com - May 7 at 9:02 AM
Monsanto CEO Hugh Grant to step down after Bayer deal closesMonsanto CEO Hugh Grant to step down after Bayer deal closes
www.theglobeandmail.com - May 7 at 9:02 AM
Monsanto CEO Hugh Grant says he will step down once the Bayer deal closesMonsanto CEO Hugh Grant says he will step down once the Bayer deal closes
finance.yahoo.com - May 7 at 9:02 AM
Monsanto says CEO Hugh Grant will step down after Bayer deal closesMonsanto says CEO Hugh Grant will step down after Bayer deal closes
finance.yahoo.com - May 7 at 9:02 AM
Bayer (BAYRY) Cut to "Sell" at ValuEngineBayer (BAYRY) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - May 5 at 2:27 PM
Bayers (BAYZF) CEO Werner Baumann on Q1 2018 Results - Earnings Call TranscriptBayer's (BAYZF) CEO Werner Baumann on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:05 AM
BASF: No key savings from Bayer agriculture assetsBASF: No key savings from Bayer agriculture assets
www.marketwatch.com - May 4 at 9:05 AM
Bayer sells further Covestro stake for 2.2 billion eurosBayer sells further Covestro stake for 2.2 billion euros
finance.yahoo.com - May 4 at 9:05 AM
Bayer A.G. beats by €0.20, misses on revenueBayer A.G. beats by €0.20, misses on revenue
seekingalpha.com - May 3 at 6:31 AM
Bayer (BAYRY) Upgraded by Zacks Investment Research to HoldBayer (BAYRY) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 2 at 12:25 PM

SEC Filings

Bayer (OTCMKTS:BAYRY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bayer (OTCMKTS:BAYRY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bayer (OTCMKTS BAYRY) Stock Chart for Sunday, June, 17, 2018

Loading chart…

This page was last updated on 6/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.